Mein Warenkorb

AD7c-NTP

Produktanfrage

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
FOR-46FOR-46; FG-3246Phase 2 ClinicalUniversity Of California San Diego, Fortis Therapeutics IncProstatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms
Details
EnadenotucirevColoAd-1; Oncolytic Ad11/Ad3Phase 1 ClinicalAkamis Bio LtdOvarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Neoplasms, Glandular and Epithelial; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
YS-5YS-5Phase 1 ClinicalFortis Therapeutics Inc, United States Department Of DefenseProstatic Neoplasms, Castration-Resistant; Prostatic Neoplasms
Details
  • Produktanfrage
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns